Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B streptococcal disease.

Irene A. Stafford, Robert D. Stewart, Jeanne Sheffield, George D. Wendel, Pablo J. Sanchez, Donald D. McIntire, Scott W. Roberts

Research output: Contribution to journalArticle

Abstract

To estimate the rate of early-onset group B streptococcal (GBS) neonatal sepsis with combined maternal and neonatal chemoprophylaxis. Since 1995, GBS chemoprophylaxis at our institution has consisted of intrapartum antibiotic prophylaxis to all women with identified risk factors. In addition, a single dose of penicillin G was administered within 1 hour of birth to all newborns without clinical signs or symptoms of infection. All neonates born between January 1, 2000, and December 31, 2008, and who developed early-onset (occurring at 72 hours of age or younger) invasive bacterial disease were identified. Incidence rates for sepsis resulting from GBS and other organisms were estimated. Compliance with risk factor identification and appropriate treatment was also ascertained. Rates of β-lactam resistance among cases of neonatal disease caused by Gram-negative organisms were calculated. Ninety-four cases of early-onset GBS sepsis were identified among 143,467 live births with a rate of 0.66 per 1,000 births (0.53-0.80 per 1,000). Of available GBS sensitivities, 8.8% demonstrated clindamycin resistance, and 26.6% were resistant to erythromycin. Thirty-four cases of non-GBS early-onset sepsis were identified for a rate of 0.24 per 1,000 live births. Of available sensitivity reports, 42.1% of Gram-negative isolates were sensitive to β-lactams. No significant difference in rates of early-onset GBS disease was found between the years 1995 and 2008. The sustained rates in early-onset GBS sepsis from 1995 to 2008, along with the low rates of neonatal disease caused by other pathogens, confirms the continued feasibility and efficacy of a combined maternal and neonatal GBS chemoprophylaxis.

Original languageEnglish (US)
Pages (from-to)123-129
Number of pages7
JournalObstetrics and Gynecology
Volume120
Issue number1
StatePublished - Jul 2012
Externally publishedYes

Fingerprint

Chemoprevention
Infant, Newborn, Diseases
Sepsis
Mothers
Lactams
Live Birth
Parturition
Newborn Infant
Penicillin G
Antibiotic Prophylaxis
Clindamycin
Erythromycin
Signs and Symptoms
Incidence
Infection
Therapeutics

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Stafford, I. A., Stewart, R. D., Sheffield, J., Wendel, G. D., Sanchez, P. J., McIntire, D. D., & Roberts, S. W. (2012). Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B streptococcal disease. Obstetrics and Gynecology, 120(1), 123-129.

Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B streptococcal disease. / Stafford, Irene A.; Stewart, Robert D.; Sheffield, Jeanne; Wendel, George D.; Sanchez, Pablo J.; McIntire, Donald D.; Roberts, Scott W.

In: Obstetrics and Gynecology, Vol. 120, No. 1, 07.2012, p. 123-129.

Research output: Contribution to journalArticle

Stafford, IA, Stewart, RD, Sheffield, J, Wendel, GD, Sanchez, PJ, McIntire, DD & Roberts, SW 2012, 'Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B streptococcal disease.', Obstetrics and Gynecology, vol. 120, no. 1, pp. 123-129.
Stafford IA, Stewart RD, Sheffield J, Wendel GD, Sanchez PJ, McIntire DD et al. Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B streptococcal disease. Obstetrics and Gynecology. 2012 Jul;120(1):123-129.
Stafford, Irene A. ; Stewart, Robert D. ; Sheffield, Jeanne ; Wendel, George D. ; Sanchez, Pablo J. ; McIntire, Donald D. ; Roberts, Scott W. / Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B streptococcal disease. In: Obstetrics and Gynecology. 2012 ; Vol. 120, No. 1. pp. 123-129.
@article{dcd5789974624bdd83e2f187d5f7d791,
title = "Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B streptococcal disease.",
abstract = "To estimate the rate of early-onset group B streptococcal (GBS) neonatal sepsis with combined maternal and neonatal chemoprophylaxis. Since 1995, GBS chemoprophylaxis at our institution has consisted of intrapartum antibiotic prophylaxis to all women with identified risk factors. In addition, a single dose of penicillin G was administered within 1 hour of birth to all newborns without clinical signs or symptoms of infection. All neonates born between January 1, 2000, and December 31, 2008, and who developed early-onset (occurring at 72 hours of age or younger) invasive bacterial disease were identified. Incidence rates for sepsis resulting from GBS and other organisms were estimated. Compliance with risk factor identification and appropriate treatment was also ascertained. Rates of β-lactam resistance among cases of neonatal disease caused by Gram-negative organisms were calculated. Ninety-four cases of early-onset GBS sepsis were identified among 143,467 live births with a rate of 0.66 per 1,000 births (0.53-0.80 per 1,000). Of available GBS sensitivities, 8.8{\%} demonstrated clindamycin resistance, and 26.6{\%} were resistant to erythromycin. Thirty-four cases of non-GBS early-onset sepsis were identified for a rate of 0.24 per 1,000 live births. Of available sensitivity reports, 42.1{\%} of Gram-negative isolates were sensitive to β-lactams. No significant difference in rates of early-onset GBS disease was found between the years 1995 and 2008. The sustained rates in early-onset GBS sepsis from 1995 to 2008, along with the low rates of neonatal disease caused by other pathogens, confirms the continued feasibility and efficacy of a combined maternal and neonatal GBS chemoprophylaxis.",
author = "Stafford, {Irene A.} and Stewart, {Robert D.} and Jeanne Sheffield and Wendel, {George D.} and Sanchez, {Pablo J.} and McIntire, {Donald D.} and Roberts, {Scott W.}",
year = "2012",
month = "7",
language = "English (US)",
volume = "120",
pages = "123--129",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B streptococcal disease.

AU - Stafford, Irene A.

AU - Stewart, Robert D.

AU - Sheffield, Jeanne

AU - Wendel, George D.

AU - Sanchez, Pablo J.

AU - McIntire, Donald D.

AU - Roberts, Scott W.

PY - 2012/7

Y1 - 2012/7

N2 - To estimate the rate of early-onset group B streptococcal (GBS) neonatal sepsis with combined maternal and neonatal chemoprophylaxis. Since 1995, GBS chemoprophylaxis at our institution has consisted of intrapartum antibiotic prophylaxis to all women with identified risk factors. In addition, a single dose of penicillin G was administered within 1 hour of birth to all newborns without clinical signs or symptoms of infection. All neonates born between January 1, 2000, and December 31, 2008, and who developed early-onset (occurring at 72 hours of age or younger) invasive bacterial disease were identified. Incidence rates for sepsis resulting from GBS and other organisms were estimated. Compliance with risk factor identification and appropriate treatment was also ascertained. Rates of β-lactam resistance among cases of neonatal disease caused by Gram-negative organisms were calculated. Ninety-four cases of early-onset GBS sepsis were identified among 143,467 live births with a rate of 0.66 per 1,000 births (0.53-0.80 per 1,000). Of available GBS sensitivities, 8.8% demonstrated clindamycin resistance, and 26.6% were resistant to erythromycin. Thirty-four cases of non-GBS early-onset sepsis were identified for a rate of 0.24 per 1,000 live births. Of available sensitivity reports, 42.1% of Gram-negative isolates were sensitive to β-lactams. No significant difference in rates of early-onset GBS disease was found between the years 1995 and 2008. The sustained rates in early-onset GBS sepsis from 1995 to 2008, along with the low rates of neonatal disease caused by other pathogens, confirms the continued feasibility and efficacy of a combined maternal and neonatal GBS chemoprophylaxis.

AB - To estimate the rate of early-onset group B streptococcal (GBS) neonatal sepsis with combined maternal and neonatal chemoprophylaxis. Since 1995, GBS chemoprophylaxis at our institution has consisted of intrapartum antibiotic prophylaxis to all women with identified risk factors. In addition, a single dose of penicillin G was administered within 1 hour of birth to all newborns without clinical signs or symptoms of infection. All neonates born between January 1, 2000, and December 31, 2008, and who developed early-onset (occurring at 72 hours of age or younger) invasive bacterial disease were identified. Incidence rates for sepsis resulting from GBS and other organisms were estimated. Compliance with risk factor identification and appropriate treatment was also ascertained. Rates of β-lactam resistance among cases of neonatal disease caused by Gram-negative organisms were calculated. Ninety-four cases of early-onset GBS sepsis were identified among 143,467 live births with a rate of 0.66 per 1,000 births (0.53-0.80 per 1,000). Of available GBS sensitivities, 8.8% demonstrated clindamycin resistance, and 26.6% were resistant to erythromycin. Thirty-four cases of non-GBS early-onset sepsis were identified for a rate of 0.24 per 1,000 live births. Of available sensitivity reports, 42.1% of Gram-negative isolates were sensitive to β-lactams. No significant difference in rates of early-onset GBS disease was found between the years 1995 and 2008. The sustained rates in early-onset GBS sepsis from 1995 to 2008, along with the low rates of neonatal disease caused by other pathogens, confirms the continued feasibility and efficacy of a combined maternal and neonatal GBS chemoprophylaxis.

UR - http://www.scopus.com/inward/record.url?scp=84871695380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871695380&partnerID=8YFLogxK

M3 - Article

VL - 120

SP - 123

EP - 129

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 1

ER -